Dedicare AB (publ) (DEDI)
Nasdaq Stockholm · Sweden · prices in SEK · close of 27 Oct 2026
Key indicators
| Last close | SEK 63.80 |
|---|---|
| 52-week range | 38.00 – 66.70 |
| Return, 1 month / 3 months | +16.0% / +16.0% |
| Return, 1 year / 3 years | +47.4% / −20.1% |
| Trend | Uptrend |
| RSI (14) | 80 |
| Volatility (1 year) | 31.3% |
| Worst drawdown (1 year) | -14.1% |
| Average daily value traded | 0.67M SEK |
| Dividend yield | 2.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Dedicare is a Swedish staffing company that supplies healthcare and social care professionals. It recruits and places doctors, nurses and other care workers on temporary and permanent assignments, and it also runs home care services. Its customers are mainly hospitals, primary care clinics, municipal care providers and private care operators, and it works across the Nordic countries from its base in Sweden. The company earns its income from staffing assignments and care contracts.
The shares are listed on the Nasdaq Stockholm in Sweden under the code DEDI, and the price on this page is in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Dedicare AB (publ) (DEDI) trades on the Nasdaq Stockholm in Sweden. It last closed at SEK 63.80 on 27 October 2026.
Its price-based Market X-Ray is 81 out of 100 (a strong price profile), ranking 37 of 912 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 47.4% and over the last three months it rose 16.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Nasdaq Stockholm
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 95 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 35.6% | ||
| From 52-week high | 0.0% | ||
| Momentum | 88 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 16.0% | ||
| 6-month return | 52.7% | ||
| 12-month return, skipping the last month | 27.1% | ||
| Stability (higher is calmer) | 88 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 31.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -14.1% | ||
| Liquidity | 54 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.67M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 56 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.7% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +20.2% |
|---|---|
| 1 month | +16.0% |
| 3 months | +16.0% |
| 6 months | +52.7% |
| 1 year | +47.4% |
| 3 years | −20.1% |
| 5 years | +7.1% |
Signals
| 50-day / 200-day average | 55.21 / 47.05 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.84 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 7 May 2026 | SEK 1.7500 |
| 29 Apr 2025 | SEK 2.5000 |
| 26 Apr 2024 | SEK 6.5000 |
| 21 Apr 2023 | SEK 6.0000 |
| 22 Apr 2022 | SEK 4.0000 |
| 23 Apr 2021 | SEK 2.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Nasdaq Stockholm; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.